| Application no. and date | 15729222.8 (espacenet) (Federated) (European Patent Register), 20150416 | | Patent/reg. no. and date | DK/EP 3134119, 20180822 | | Publication date | 20170301 | | Priority no. and date | US 201461983951 P, 20140424 | | EP pub. no. and date |
EP 3134119 20170301 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81803083DK00E | | Inventor | MARTINI, Jean-Francois Andre, 7420 Circulo Sequoia
Carlsbad, California 92009, US,
TARAZI, Jamal Christo, 10867 Pesos Place
San Diego, California 92124, US,
WILLIAMS, James Andrew, c/o Pfizer Inc.
10555 Science Center Drive
San Diego, California 92121, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , G01N 33/574 (2006.01) | | Title | CANCERBEHANDLING | | Int. application no. | IB2015052796 | | Int. publication no. | WO2015162532 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
